PAS kinase is required for normal cellular energy balance

The metabolic syndrome, a complex set of phenotypes typically associated with obesity and diabetes, is an increasing threat to global public health. Fundamentally, the metabolic syndrome is caused by a failure to properly sense and respond to cellular metabolic cues. We studied the role of the cellular metabolic sensor PAS kinase (PASK) in the pathogenesis of metabolic disease by using PASK−/− mice. We identified tissue-specific metabolic phenotypes caused by PASK deletion consistent with its role as a metabolic sensor. Specifically, PASK−/− mice exhibited impaired glucose-stimulated insulin secretion in pancreatic β-cells, altered triglyceride storage in liver, and increased metabolic rate in skeletal muscle. Further, PASK deletion caused nearly complete protection from the deleterious effects of a high-fat diet including obesity and insulin resistance. We also demonstrate that these cellular effects, increased rate of oxidative metabolism and ATP production, occur in cultured cells. We therefore hypothesize that PASK acts in a cell-autonomous manner to maintain cellular energy homeostasis and is a potential therapeutic target for metabolic disease.

[1]  G. Camenisch,et al.  Glucose-Stimulated Insulin Production in Mice Deficient for the PAS Kinase PASKIN , 2007, Diabetes.

[2]  S. Marshall.  Role of Insulin, Adipocyte Hormones, and Nutrient-Sensing Pathways in Regulating Fuel Metabolism and Energy Homeostasis: A Nutritional Perspective of Diabetes, Obesity, and Cancer , 2006, Science's STKE.

[3]  M. Miyazaki,et al.  Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance. , 2006, The Journal of clinical investigation.

[4]  R. Evans,et al.  A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway* , 2006, Journal of Biological Chemistry.

[5]  R. Westerberg,et al.  Fatty acid elongases in mammals: their regulation and roles in metabolism. , 2006, Progress in lipid research.

[6]  E. Abel,et al.  Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity , 2005, Circulation.

[7]  A. Dobrzyń,et al.  Stearoyl‐CoA desaturase as a new drug target for obesity treatment , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[8]  Michael Courtois,et al.  PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis , 2005, PLoS Biology.

[9]  Christopher J. Rhodes,et al.  Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.

[10]  M. Lazar,et al.  How Obesity Causes Diabetes: Not a Tall Tale , 2005, Science.

[11]  J. Lindsley,et al.  Nutrient sensing and metabolic decisions. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[12]  B. Manning.  Balancing Akt with S6K , 2004, The Journal of cell biology.

[13]  R. Cooksey,et al.  Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. , 2004, Endocrinology.

[14]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[15]  G. Rutter,et al.  Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Wear.  CIRCULATION , 1964, The Lancet.

[17]  Kun-Liang Guan,et al.  Dysregulation of the TSC-mTOR pathway in human disease , 2004, Nature Genetics.

[18]  M. Gassmann,et al.  Targeted Disruption of the Mouse PAS Domain Serine/Threonine Kinase PASKIN , 2003, Molecular and Cellular Biology.

[19]  B. Spiegelman,et al.  Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. , 2003, The Journal of clinical investigation.

[20]  B. Teusink,et al.  Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. , 2003, Endocrinology.

[21]  B. Brewer,et al.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. , 2003, The Journal of clinical investigation.

[22]  Jared Rutter,et al.  PAS Domains and Metabolic Status Signaling , 2002, Science.

[23]  C. Proud,et al.  Regulation of mammalian translation factors by nutrients. , 2002, European journal of biochemistry.

[24]  Jared Rutter,et al.  Structure and interactions of PAS kinase N-terminal PAS domain: model for intramolecular kinase regulation. , 2002, Structure.

[25]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Sone,et al.  Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. , 2002, Journal of lipid research.

[27]  S. Kliewer,et al.  Regulation of cyp3a gene transcription by the pregnane x receptor. , 2002, Annual review of pharmacology and toxicology.

[28]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[29]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[30]  K. Gardner,et al.  PAS kinase: An evolutionarily conserved PAS domain-regulated serine/threonine kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[32]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[33]  L. Tecott,et al.  Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by , 2000, Endocrinology.

[34]  M. Miyazaki,et al.  The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1* , 2000, The Journal of Biological Chemistry.

[35]  M. Prentki,et al.  Molecular or Pharmacologic Perturbation of the Link between Glucose and Lipid Metabolism Is without Effect on Glucose-stimulated Insulin Secretion , 1998, The Journal of Biological Chemistry.

[36]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[37]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[38]  M. Carlson,et al.  The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.

[39]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[40]  M. Feinglos,et al.  Diet-Induced Type II Diabetes in C57BL/6J Mice , 1988, Diabetes.